ADMA Biologics, Inc.

ADMANASDAQHealthcare● Active

$8.04

+$0.07(+0.82%)

Market Cap$1.9B

P/E Ratio—

52W High$22.37

52W Low$7.21

Avg Volume7.0M

Open$7.89

Beta0.73

Insider Trades Ownership Employees

ADMA Biologics, Inc. (ADMA) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · ADMA · as of Jun 8, 2026

Activity summary

Buy transactions

P-Purchase only

Sell transactions

12 Months

Buy/Sell ratio

0.29

Buy/Sell (by trades)

Overall sentiment

BEARISH

↑ Buy 23%Active transactions only · RSU vesting excluded77% Sell ↓

ADMA Biologics, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 8, 2026

ADMA insider buying and selling by quarter

ADMA insider selling · ADMA insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling

1.7M865K0

2024 Q3

2024 Q4

2025 Q1

2025 Q2

2025 Q3

2025 Q4

2026 Q1

2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 8, 2026

Active insiders

Most active in past 12 months · ADMA ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

ADMA executive sell shares · ADMA board member insider trading · ADMA insider trading SEC filing

Showing 74 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Date	Insider	Type	Shares	Price	Value	After trans.	Filing
May 27, 2026	Grossman Jerrold B Director	Purchase	6,400	$7.91	$51K	520,284	Form 4
May 12, 2026	Grossman Jerrold B Director	Purchase	12,500	$8.01	$100K	513,884	Form 4
May 11, 2026	Grossman Jerrold B Director	Purchase	12,500	$8.01	$100K	501,384	Form 4
Apr 1, 2026	Kestenberg-Messina Kaitlin M. COO and SVP, Compliance	Other	20,362	$9.11	$185K	446,238	Form 4
Mar 13, 2026	Guiheen Lawrence P. Director	Option	30,000	$3.66	$110K	135,520	Form 4
Mar 17, 2026	Guiheen Lawrence P. Director	Gift	30,000	—	—	105,520	Form 4
Mar 17, 2026	Guiheen Lawrence P. Director	Gift	30,000	—	—	30,000	Form 4
Mar 16, 2026	Grossman Adam S President and CEO · Director	Option	15,000	$5.40	$81K	2,133,777	Form 4
Mar 16, 2026	Grossman Adam S President and CEO · Director	Sale	15,000	$15.16	$227K	2,118,777	Form 4
Mar 16, 2026	Grossman Adam S President and CEO · Director	Sale	6,000	$15.16	$91K	2,112,777	Form 4
Mar 6, 2026	Kestenberg-Messina Kaitlin M. COO and SVP, Compliance	Other	10,059	$15.39	$155K	562,101	Form 4
Mar 7, 2026	Kestenberg-Messina Kaitlin M. COO and SVP, Compliance	Other	4,235	$15.39	$65K	557,866	Form 4
Mar 9, 2026	Kestenberg-Messina Kaitlin M. COO and SVP, Compliance	Option	2,175	$1.55	$3K	476,696	Form 4
Mar 9, 2026	Kestenberg-Messina Kaitlin M. COO and SVP, Compliance	Option	1,525	$2.35	$4K	474,521	Form 4
Mar 9, 2026	Kestenberg-Messina Kaitlin M. COO and SVP, Compliance	Option	2,646	$2.83	$7K	472,996	Form 4
Mar 9, 2026	Kestenberg-Messina Kaitlin M. COO and SVP, Compliance	Option	1,250	$4.31	$5K	470,350	Form 4
Mar 9, 2026	Kestenberg-Messina Kaitlin M. COO and SVP, Compliance	Option	2,500	$5.00	$13K	469,100	Form 4
Mar 9, 2026	Kestenberg-Messina Kaitlin M. COO and SVP, Compliance	Other	91,266	—	—	466,600	Form 4
Mar 9, 2026	Kestenberg-Messina Kaitlin M. COO and SVP, Compliance	Sale	10,096	$15.63	$158K	466,600	Form 4
Mar 6, 2026	Grossman Adam S President and CEO · Director	Other	56,438	$15.39	$869K	2,148,290	Form 4
Mar 7, 2026	Grossman Adam S President and CEO · Director	Other	29,513	$15.39	$454K	2,118,777	Form 4
Mar 6, 2026	ELMS STEVE Director	Purchase	7,000	$15.39	$108K	2,045,730	Form 4
Mar 5, 2026	ELMS STEVE Director	Purchase	7,000	$15.67	$110K	2,038,730	Form 4
Feb 26, 2026	Grossman Adam S President and CEO · Director	Other	54,858	$15.18	$833K	2,204,728	Form 4
Feb 19, 2026	Kestenberg-Messina Kaitlin M. COO and SVP, Compliance	Other	8,161	$16.32	$133K	572,160	Form 4

Grossman Jerrold B

Director

Purchase

Date

May 27

6,400

Price

$7.91

Value

$51K

View Form 4 on SEC.gov

Grossman Jerrold B

Director

Purchase

Date

May 12

12,500

Price

$8.01

Value

$100K

View Form 4 on SEC.gov

Grossman Jerrold B

Director

Purchase

Date

May 11

12,500

Price

$8.01

Value

$100K

View Form 4 on SEC.gov

Kestenberg-Messina Kaitlin M.

COO and SVP, Compliance

Other

Date

Apr 1

20,362

Price

$9.11

Value

$185K

View Form 4 on SEC.gov

Guiheen Lawrence P.

Director

Option

Date

Mar 13

30,000

Price

$3.66

Value

$110K

View Form 4 on SEC.gov

Guiheen Lawrence P.

Director

Gift

Date

Mar 17

30,000

Price

—

Value

—

View Form 4 on SEC.gov

Guiheen Lawrence P.

Director

Gift

Date

Mar 17

30,000

Price

—

Value

—

View Form 4 on SEC.gov

Grossman Adam S

President and CEO · Director

Option

Date

Mar 16

15,000

Price

$5.40

Value

$81K

View Form 4 on SEC.gov

Grossman Adam S

President and CEO · Director

Sale

Date

Mar 16

15,000

Price

$15.16

Value

$227K

View Form 4 on SEC.gov

Grossman Adam S

President and CEO · Director

Sale

Date

Mar 16

6,000

Price

$15.16

Value

$91K

View Form 4 on SEC.gov

Kestenberg-Messina Kaitlin M.

COO and SVP, Compliance

Other

Date

Mar 6

10,059

Price

$15.39

Value

$155K

View Form 4 on SEC.gov

Kestenberg-Messina Kaitlin M.

COO and SVP, Compliance

Other

Date

Mar 7

4,235

Price

$15.39

Value

$65K

View Form 4 on SEC.gov

Kestenberg-Messina Kaitlin M.

COO and SVP, Compliance

Option

Date

Mar 9

2,175

Price

$1.55

Value

$3K

View Form 4 on SEC.gov

Kestenberg-Messina Kaitlin M.

COO and SVP, Compliance

Option

Date

Mar 9

1,525

Price

$2.35

Value

$4K

View Form 4 on SEC.gov

Kestenberg-Messina Kaitlin M.

COO and SVP, Compliance

Option

Date

Mar 9

2,646

Price

$2.83

Value

$7K

View Form 4 on SEC.gov

Kestenberg-Messina Kaitlin M.

COO and SVP, Compliance

Option

Date

Mar 9

1,250

Price

$4.31

Value

$5K

View Form 4 on SEC.gov

Kestenberg-Messina Kaitlin M.

COO and SVP, Compliance

Option

Date

Mar 9

2,500

Price

$5.00

Value

$13K

View Form 4 on SEC.gov

Kestenberg-Messina Kaitlin M.

COO and SVP, Compliance

Other

Date

Mar 9

91,266

Price

—

Value

—

View Form 4 on SEC.gov

Kestenberg-Messina Kaitlin M.

COO and SVP, Compliance

Sale

Date

Mar 9

10,096

Price

$15.63

Value

$158K

View Form 4 on SEC.gov

Grossman Adam S

President and CEO · Director

Other

Date

Mar 6

56,438

Price

$15.39

Value

$869K

View Form 4 on SEC.gov

Grossman Adam S

President and CEO · Director

Other

Date

Mar 7

29,513

Price

$15.39

Value

$454K

View Form 4 on SEC.gov

ELMS STEVE

Director

Purchase

Date

Mar 6

7,000

Price

$15.39

Value

$108K

View Form 4 on SEC.gov

ELMS STEVE

Director

Purchase

Date

Mar 5

7,000

Price

$15.67

Value

$110K

View Form 4 on SEC.gov

Grossman Adam S

President and CEO · Director

Other

Date

Feb 26

54,858

Price

$15.18

Value

$833K

View Form 4 on SEC.gov

Kestenberg-Messina Kaitlin M.

COO and SVP, Compliance

Other

Date

Feb 19

8,161

Price

$16.32

Value

$133K

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 3

▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About ADMA insider trading

ADMA insider trades

ADMA Biologics, Inc. (ADMA) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Grossman Adam S (President and CEO · Director), Kestenberg-Messina Kaitlin M. (COO and SVP, Compliance), ELMS STEVE (Director). Over the past 12 months, 5 insiders have filed transactions with the SEC. ADMA insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For ADMA Biologics, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic

acquisitionOrDisposition field:

A = Acquisition (buy) · D = Disposition (sell)

RSU vesting (M-Exempt) excluded from sentiment

Form 4SEC filing required within 2 business days of any insider transaction

10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot

Open MktDirect purchase or sale on the open market (excludes awards, options)

Ownership SEC filings Financial statements Price history Forecast & ratings Earnings

Frequently asked questions

ADMA insider trading · 5 questions

The insiders of ADMA Biologics, Inc. (ADMA) include executives and directors such as Grossman Adam S (President and CEO · Director), Kestenberg-Messina Kaitlin M. (COO and SVP, Compliance), ELMS STEVE (Director), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

ADMA board member insider tradingwho are ADMA insidersADMA insider rosterADMA Biologics, Inc. executives insider activity

▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026